Cyclin D1 is a strong prognostic factor for survival in pancreatic cancer: Analysis of CD G870A polymorphism, FISH and immunohistochemistry-Reference-Cited by-同舟云学术

Cyclin D1 is a strong prognostic factor for survival in pancreatic cancer: Analysis of CD G870A polymorphism, FISH and immunohistochemistry

Published:2014-12-02 Issue:3 Volume:111 Page:316-323
ISSN:0022-4790
Container-title:Journal of Surgical Oncology
language:en
Short-container-title:J. Surg. Oncol.

Author:

Bachmann Kai¹,Neumann Anna¹,Hinsch Andrea²,Nentwich Michael F.¹,El Gammal Alexander T.¹,Vashist Yogesh¹,Perez Daniel¹,Bockhorn Maximilian¹,Izbicki Jakob R.¹,Mann Oliver¹

Affiliation:

1. Department of General, Visceral and Thoracic Surgery; University Medical Center Hamburg-Eppendorf; Hamburg Germany

2. Department of Pathology; University Medical Center Hamburg-Eppendorf; Hamburg Germany

Publisher

Wiley

Subject

Oncology,General Medicine,Surgery

Reference53 articles.

1. Cancer statistics;Jemal;CA Cancer J Clin,2007

2. Pancreatic carcinogenesis;Koorstra;Pancreatology,2008

3. Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice;Wang;Nature,1994

4. Alternate splicing produces a novel cyclin D1 transcript;Betticher;Oncogene,1995

5. Mechanism of cyclin D1 (CCND1, PRAD1) overexpression in human cancer cells: Analysis of allele-specific expression;Hosokawa;Genes Chromosomes Cancer,1998

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. CCND1 as a Prognostic and Diagnostic Biomarker and the Impact of Its Epigenetic Alterations on Cancer Survival;Cureus;2024-07-27

2. Prognostic Value of Histone Acetyl Transferase 1 (HAT-1) and Inflammatory Signatures in Pancreatic Cancer;Current Issues in Molecular Biology;2024-04-25

3. CCND1 Amplification in Pancreatic Ductal and Ampullary Adenocarcinoma and Its Impact on Patients’ Survival: a Single-Center Observational Study;Indian Journal of Surgical Oncology;2022-11-12

4. Immunohistochemical analysis of a panel of cancer stem cell markers and potential therapeutic markers in pancreatic ductal adenocarcinoma;Journal of Cancer Research and Clinical Oncology;2022-09-06

5. Implication of ERBB2 as a Predictive Tool for Survival in Patients with Pancreatic Cancer in Histological Studies;Current Oncology;2022-03-30